|
1) Pui CH, Robison LL, Look AT. Acute lymphoblastic leukaemia. Lancet. 2008; 371: 1030-43
|
|
|
|
2) Grabher C, von Boehmer H, Look AT. Notch 1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia. Nat Rev Cancer. 2006; 6: 347-59
|
|
|
|
|
|
3) Graux C, Cools J, Michaux L, et al. Cytogenetics and molecular genetics of T-cell acute lymphoblastic leukemia: from thymocyte to lymphoblast. Leukemia. 2006; 20: 1496-510
|
|
|
|
|
|
4) Hayashi Y. The molecular genetics of recurring chromosome abnormalities in acute myeloid leukemia. Semin Hematol. 2007; 37: 368-80
|
|
|
|
|
|
5) Graux C, Cools J, Melotte C, et al. Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia. Nat Genet. 2004; 36: 1084-9
|
|
|
|
|
|
6) De Keersmaecker K, Graux C, Odero MD, et al. Fusion of EML1 to ABL1 in T-cell acute lymphoblastic leukemia with cryptic t(9; 14)(q34; q32). Blood. 2005; 105: 4849-52
|
|
|
|
|
|
7) Ballerini P, Busson M, Fasola S, et al. NUP214-ABL1 amplification in t(5; 14)/HOX11L2-positive ALL present with several forms and may have a prognostic significance. Leukemia. 2005; 19: 468-70
|
|
|
|
|
|
8) Hayashi Y, Yamamoto K, Kojima S. T-cell acute lymphoblastic leukemias with a t(8; 14) possibly involving a c-myc locus and T-cell-receptor alpha-chain genes. N Engl J Med. 1986; 314: 650-1
|
|
|
|
|
|
9) Hatano M, Roberts CW, Minden M, et al. Deregulation of a homeobox gene, HOX11, by the t(10; 14) in T cell leukemia. Science. 1991; 253: 79-82
|
|
|
|
|
|
10) Kikuchi A, Hayashi Y, Kobayashi S, et al. Clinical significance of TAL1 gene alteration in childhood T-cell acute lymphoblastic leukemia and lymphoma. Leukemia. 1993; 7: 933-8
|
|
|
|
|
|
11) Ellisen LW, Bird J, West DC, et al. TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell. 1991; 66: 649-61
|
|
|
|
|
|
12) Rubnitz JE, Camitta BM, Mahmoud H, et al. Childhood acute lymphoblastic leukemia with the MLL-ENL fusion and t(11; 19)(q23; p13. 3) translocation. J Clin Oncol. 1999; 17: 191-6
|
|
|
|
|
|
13) Asnafi V, Radford-Weiss I, Dastugue N, et al. CALM-AF10 is a common fusion transcript in T-ALL and is specific to the TCR gamma delta lineage. Blood. 2003; 102: 1000-6
|
|
|
|
|
|
14) Mikhail FM, Coignet L, Hatem N, et al. A novel gene, FGA7, is fused to RUNX1/AML1 in a t(4; 21)(q28; q22) in a patient with T-cell acute lymphoblastic leukemia. Genes Chromosomes Cancer. 2004; 39: 110-8
|
|
|
|
|
|
15) Chinen Y, Taki T, Nishida K, et al. Identification of the novel AML1 fusion partner gene, LAF4, a fusion partner of MLL, in childhood T-cell acute lymphoblastic leukemia with t(2; 21)(q11; q22) by bubble PCR method for cDNA. Oncogene. 2008; 27: 2249-56
|
|
|
|
|
|
16) Ohnishi H, Kawamura M, Ida K, et al. Homozygous deletions of p16/MTS1 gene are frequent but mutations are infrequent in childhood T-cell acute lymphoblastic leukemia. Blood. 1995; 86: 1269-75
|
|
|
|
|
|
17) Hayashi Y, Raimondi SC, Look AT, et al. Abnormalities of the long arm of chromosome 6 in childhood acute lymphoblastic leukemia. Blood. 1990; 76: 1626-30
|
|
|
|
|
|
18) Kawamura M, Ohnishi H, Guo SX, et al. Alterations of the p53, p21, p16, p15 and RAS genes in childhood T-cell acute lymphoblastic leukemia. Leuk Res. 1999; 23: 115-26
|
|
|
|
|
|
19) Ferrando AA, Neuberg DS, Staunton J, et al. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell. 2002; 1: 75-87
|
|
|
|
|
|
20) Ferrando AA, Armstrong SA, Neuberg DS, et al. Gene expression signatures in MLL-rearranged T-lineage and B-precursor acute leukemias: dominance of HOX dysregulation. Blood. 2003; 102: 262-8
|
|
|
|
|
|
21) Ferrando AA, Neuberg DS, Dodge RK, et al. Prognostic importance of TLX1 (HOX11) oncogene expression in adults with T-cell acute lymphoblastic leukaemia. Lancet. 2004; 363: 535-6
|
|
|
|
|
|
22) Mullighan CG, Goorha S, Radtke I, et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature. 2007; 446: 758-64
|
|
|
|
|
|
23) Pear WS, Aster JC, Scott ML, et al. Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles. J Exp Med. 1996; 183: 2283-91
|
|
|
|
|
|
24) Bellavia D, Campese AF, Alesse E, et al. Constitutive activation of NF-kappaB and T-cell leukemia/lymphoma in Notch3 transgenic mice. EMBO J. 2000; 19: 3337-48
|
|
|
|
|
|
25) Capobianco AJ, Zagouras P, Blaumueller CM, et al. Neoplastic transformation by truncated alleles of human NOTCH1/TAN1 and NOTCH2. Mol Cell Biol. 1997; 17: 6265-73
|
|
|
|
|
|
26) Weijzen S, Rizzo P, Braid M, et al. Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells. Nat Med. 2002; 8: 979-86
|
|
|
|
|
|
27) Chiaramonte R, Calzavara E, Balordi F, et al. Differential regulation of Notch signal transduction in leukaemia and lymphoma cells in culture. J Cell Biochem. 2003; 88: 569-77
|
|
|
|
|
|
28) Weng AP, Ferrando AA, Lee W, et al. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science. 2004; 306: 269-71
|
|
|
|
|
|
29) Lee SY, Kumano K, Masuda S, et al. Mutations of the Notch1 gene in T-cell acute lymphoblastic leukemia: analysis in adults and children. Leukemia. 2005; 19: 1841-3
|
|
|
|
|
|
30) Breit S, Stanulla M, Flohr T, et al. Activating NOTCH1 mutations predict favorable early treatment response and long-term outcome in childhood precursor T-cell lymphoblastic leukemia. Blood. 2006; 108: 1151-7
|
|
|
|
|
|
31) Zhu YM, Zhao WL, Fu JF, et al. NOTCH1 mutations in T-cell acute lymphoblastic leukemia: prognostic significance and implication in multifactorial leukemogenesis. Clin Cancer Res. 2006; 12: 3043-9
|
|
|
|
|
|
32) van Grotel M, Meijerink JP, van Wering ER, et al. Prognostic significance of molecular-cytogenetic abnormalities in pediatric T-ALL is not explained by immunophenotypic differences. Leukemia. 2008; 22: 124-31
|
|
|
|
|
|
33) Park MJ, Taki T, Oda M, et al. FBW7 and NOTCH1 mutations in childhood T-cell acute lymphoblastic leukemia and T cell non-Hodgkin's lymphoma. (submitted)
|
|
|
|
|
|
34) Moberg KH, Bell DW, Wahrer DC, et al. Archipelago regulates cyclin E levels in Drosophila and is mutated in human cancer cell lines. Nature. 2001; 413: 311-6
|
|
|
|
|
|
35) O'Neil J, Grim J, Strack P, et al. FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to gamma-secretase inhibitors. J Exp Med. 2007; 204: 1813-24
|
|
|
|
|
|
36) Thompson BJ, Buonamici S, Sulis ML, et al. The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemia. J Exp Med. 2007; 204: 1825-35
|
|
|
|
|
|
37) Malyukova A, Dohda T, von der Lehr N, et al. The tumor suppressor gene hCDC4 is frequently mutated in human T-cell acute lymphoblastic leukemia with functional consequences for Notch signaling. Cancer Res. 2007; 67: 5611-6
|
|
|
|
|
|
38) Matsuoka S, Oike Y, Onoyama I, et al. Fbxw7 acts as a critical fail-safe against premature loss of hematopoietic stem cells and development of T-ALL. Genes Dev. 2008; 22: 986-91
|
|
|
|
|
|
39) Welcker M, Clurman BE. FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation. Nat Rev Cancer. 2008; 8: 83-93
|
|
|
|
|